Advertisement

Treating HER2+ Metastatic Breast Cancer: Caitlin’s Story

Sara A. Hurvitz, MD, discusses information about HER2+ metastatic breast cancer with one of her patients, Caitlin Flanagan, as she shares her personal journey with breast cancer.

EP. 1: Classifying Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.

EP. 2: Being Diagnosed With HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.

EP. 3: Understanding Treatment Options for HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.

EP. 4: Understanding HER2+ Metastatic Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.

EP. 5: Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.

EP. 6: Goals of Treatment After Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.

EP. 7: Advances in HER2+ Metastatic Breast Cancer

March 30th 2021

Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.

EP. 8: Tucatinib With Chemotherapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.

EP. 9: Adhering to Oral Therapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.

EP. 10: Treating HER2+ Metastatic Breast Cancer During the COVID-19 Pandemic

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.

Advertisement
Advertisement